Financhill
Buy
71

ISRG Quote, Financials, Valuation and Earnings

Last price:
$577.40
Seasonality move :
2.22%
Day range:
$575.03 - $579.85
52-week range:
$425.00 - $616.00
Dividend yield:
0%
P/E ratio:
76.39x
P/S ratio:
21.83x
P/B ratio:
12.09x
Volume:
355.2K
Avg. volume:
1.7M
1-year change:
7.47%
Market cap:
$204.6B
Revenue:
$8.4B
EPS (TTM):
$7.56

Earnings Data

Next earnings date for ISRG
Jan 22
2026
Most recent earnings per share
$1.95
Missed by $0.04
(Oct 21/2025)
Consensus Estimate
$1.99
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ISRG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/22/2026 Q4 $2.7B -- -- $2.25 --
10/21/2025 Q3 $2.4B $2.5B $1.95 $1.99 -$0.04
07/22/2025 Q2 $2.4B $2.4B $1.81 $1.92 -$0.11
04/22/2025 Q1 $2.2B $2.3B $1.92 $1.73 $0.18
01/23/2025 Q4 $2.2B $2.4B $1.88 $1.79 $0.10
10/17/2024 Q3 $2B $2B $1.56 $1.64 -$0.08
07/18/2024 Q2 $2B $2B $1.46 $1.54 -$0.08
04/18/2024 Q1 $1.9B $1.9B $1.51 $1.42 $0.10
01/23/2024 Q4 $1.9B $1.9B $1.69 $1.49 $0.21
10/19/2023 Q3 -- $1.7B $1.16 -- --
07/20/2023 Q2 -- $1.8B $1.18 -- --
04/18/2023 Q1 -- $1.7B $1.00 -- --
01/24/2023 Q4 -- $1.7B $0.91 -- --
10/18/2022 Q3 -- $1.6B $0.90 -- --
07/21/2022 Q2 -- $1.5B $0.85 -- --
04/21/2022 Q1 -- $1.5B $1.00 -- --
01/20/2022 Q4 -- $1.6B $1.04 -- --
10/19/2021 Q3 -- $1.4B $1.04 -- --
07/20/2021 Q2 -- $1.5B $1.42 -- --
04/20/2021 Q1 -- $1.3B $1.17 -- --
01/21/2021 Q4 -- $1.3B $1.01 -- --
10/15/2020 Q3 -- $1.1B $0.87 -- --
07/21/2020 Q2 -- $852.1M $0.19 -- --
04/16/2020 Q1 -- $1.1B $0.87 -- --
01/23/2020 Q4 -- $1.3B $1.00 -- --
10/17/2019 Q3 -- $1.1B $1.11 -- --
07/18/2019 Q2 -- $1.1B $0.89 -- --
04/18/2019 Q1 -- $973.7M $0.85 -- --
01/24/2019 Q4 -- $1B $0.82 -- --
10/18/2018 Q3 -- $920.9M $0.82 -- --
07/19/2018 Q2 -- $909.3M $0.72 -- --
04/17/2018 Q1 -- $847.5M $0.81 -- --
01/25/2018 Q4 -- $892M -$0.09 -- --
10/19/2017 Q3 -- $807.8M $0.85 -- --
07/20/2017 Q2 -- $758.8M $0.65 -- --
04/18/2017 Q1 -- $679.6M $0.52 -- --
01/24/2017 Q4 -- $754.7M $0.57 -- --
10/18/2016 Q3 -- $684.3M $0.59 -- --
07/19/2016 Q2 -- $670.9M $0.52 -- --
04/19/2016 Q1 -- $593.6M $0.39 -- --
01/21/2016 Q4 -- $674.4M $0.55 -- --

Intuitive Surgical, Inc. Earnings Questions

  • How Much did Intuitive Surgical, Inc. Generate in Revenue Last Quarter?

    Intuitive Surgical, Inc. reported $2.5B worth of top line sales in its most recent quarter.

  • Did Intuitive Surgical, Inc. Beat Earnings Last Quarter?

    Intuitive Surgical, Inc. announced earnings per share of $1.95 which represents a miss of analyst forecast a $1.99 per share.

  • Is Intuitive Surgical, Inc. Profitable?

    Intuitive Surgical, Inc. reported $1.7B that represents $4.59 per share over the last quarter.

  • What is the Analyst Consensus for Intuitive Surgical, Inc. EPS Next Year?

    Intuitive Surgical, Inc.'s earnings are forecast to grow from $6.42 per share to $6.92 per share next year representing an increase of 34.69%.

  • When is Intuitive Surgical, Inc.'s Earnings Date?

    Intuitive Surgical, Inc.'s next earnings date is January 22, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock